2-phenylpyridine has been researched along with Atherosclerotic Parkinsonism in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grimes, JD; Hassan, MN; Thakar, JH | 1 |
| Hansen, S; Jones, K; Perry, TL; Wall, RA | 1 |
2 other study(ies) available for 2-phenylpyridine and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Behavioral and biochemical effects of 4-phenylpyridine, 2-phenylpyridine, and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in rodents.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Brain; Corpus Striatum; Dopamine; Male; Mice; Mice, Inbred C57BL; Mitochondria; Motor Activity; Oxidative Phosphorylation; Parkinson Disease, Secondary; Pyridines; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1990 |
2-Phenylpyridine and 3-phenylpyridine, constituents of tea, are unlikely to cause idiopathic Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Female; Homovanillic Acid; Mice; Mice, Inbred C57BL; Neurotoxins; Parkinson Disease, Secondary; Pyridines; Reference Values; Tea | 1988 |